Neuromodulation beyond itch is blocked by targeting IL-13Rα1 with eblasakimab
Yannick Miron, Paul Miller, Carl Firth and Ferda Cevikbas
32nd European Academy of Dermatology and Venereology Congress (EADV), October 2023
The Website may contain links to or from other websites, over which ASLAN has no control. These linked sites are for your convenience only and you access them at your own risk.
ASLAN is not responsible for the content of the linked sites. ASLAN does not in any way endorse the linked sites.
Read about our latest product developments and partnerships, industry advances and events.